Actemra IV injection 400 mg, from Chugai Pharmaceutical, features Tocilizumab (genetically recombination). This injectable drug (YJ code: 6399421A3022) comes as 400mg in 20mL per bottle and is used for conditions such as rheumatoid arthritis, giant cell arteritis, and systemic sclerosis-associated interstitial lung disease.
Actemra IV injection 400 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →